Skip to main content

Table 1 Patient and tumour characteristics*

From: Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events

Factor AR negative n = 32 (%) AR positiven = 41 (%)
Age (years)   
≤35 1 (3.0) 1 (2.4)
≥35 31 (97.0) 40 (97.6)
Estrogen receptor   
Negative 23 (72.0) 9 (22.5)
Positive 9 (28.0) 31 (77.5)
Progesterone receptor   
Negative 27 (87.0) 16 (39.0)
Positive 4 (13.0) 25 (61.0)
HER2   
Negative 18 (85.7) 25 (75.8)
Positive 3 (14.3) 8 (24.2)
Triple negativea   
No 6 (28.6) 30 (90.9)
Yes 15 (71.4) 3 (9.1)
  1. *All patients were diagnosed with Stage III disease, as defined in the Materials and Methods section of the manuscript
  2. aTriple negative breast cancer represents tumours displaying negative expression for estrogen receptor, progesterone receptor and HER2 by IHC. AR, androgen receptor; HER2, human epidermal growth factor receptor type 2.
\